Experiment 449654
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | CASSIDY,J: GRAHAM,MA: HUININK,WTB: MC DANIEL,C: SETANOIANS,A: RANKIN,EM: KERR,DJ: KAYE,SB:. (1993). PHASE I CLINICAL STUDY OF LL-D49194-ALPHA-1 WITH RETROSPECTIVE PHARMACOKINETIC INVESTIGATIONS IN MICE AND HUMANS.. 31(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | PHASE 1 STUDY IN 15 PATIENTS OF ANTITUMOR ACTIVITY. TOXIC EFFECTS INCLUDED NAUSEA, VOMITING AND CARDIOTOXICITY. ST AND T WAVE CHANGES SEEN AT HIGHEST (4.0 MG/SO M) AND LOWEST[(GIVEN)] DOSES. STUDY TERMINATED PREMATURELY SECONDARY TO CARDIOTOXICITY. |
| Dose amount | 0.25 MG |
| Number | 5 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |